Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
作者： Norio Yasui-Furukori , Masamichi Ishioka , Norio Sugawara , Hanako Furukori , Shuhei Kudo
DOI: 10.2147/NDT.S75176
关键词: Coagulation 、 Internal medicine 、 Prolactin level 、 Bioinformatics 、 Venous thromboembolism 、 Medicine 、 Incidence (epidemiology) 、 Prolactin
摘要: Objective The strong association between psychiatric patients who receive antipsychotics and the incidence of venous thromboembolism (VTE) is known. Although previous reports suggest that hyperprolactinemia often increases markers activated coagulation, few studies have examined direct relationship prolactin level elevated by coagulation.
paperity.org参考文章(42)
René Thomassen, Jan P. Vandenbroucke, Frits R. Rosendaal, Antipsychotic medication and venous thrombosis. British Journal of Psychiatry. ,vol. 179, pp. 63- 66 ,(2001) , 10.1192/BJP.179.1.63
Norio Yasui-Furukori, Hanako Furukori, Norio Sugawara, Akira Fujii, Sunao Kaneko, Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. Journal of Clinical Psychopharmacology. ,vol. 30, pp. 596- 599 ,(2010) , 10.1097/JCP.0B013E3181EE832D
Nana-Maria Heida, Katrin Schäfer, Stavros Konstantinides, Prolactin as a modulator of platelet function and thrombosis: the end of the story, or a new beginning? Thrombosis and Haemostasis. ,vol. 101, pp. 991- 992 ,(2009) , 10.1160/TH09-04-0275
Diane M. Becker, Jodi Segal, Dhananjay Vaidya, Lisa R. Yanek, J. Enrique Herrera-Galeano, Paul F. Bray, Taryn F. Moy, Lewis C. Becker, Nauder Faraday, Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA. ,vol. 295, pp. 1420- 1427 ,(2006) , 10.1001/JAMA.295.12.1420
E. Dunn, P. Grant, Type 2 diabetes: an atherothrombotic syndrome. Current Molecular Medicine. ,vol. 5, pp. 323- 332 ,(2005) , 10.2174/1566524053766059
Satoko Hamanaka, Yoshito Kamijo, Tomonori Nagai, Katsuyoshi Kurihara, Katsutoshi Tanaka, Kazui Soma, Hitoshi Miyaoka, Massive Pulmonary Thromboembolism Demonstrated at Necropsy in Japanese Psychiatric Patients Treated With Neuroleptics Including Atypical Antipsychotics Circulation. ,vol. 68, pp. 850- 852 ,(2004) , 10.1253/CIRCJ.68.850
Inan Anaforoglu, Melek Eda Ertorer, Ilknur Kozanoglu, Birsel Unal, Filiz Eksi Haydardedeoglu, Okan Bakiner, Emre Bozkirli, Neslihan Bascil Tutuncu, Nilgun Guvener Demirag, Macroprolactinemia, like hyperprolactinemia, may promote platelet activation Endocrine. ,vol. 37, pp. 294- 300 ,(2010) , 10.1007/S12020-009-9304-X
K. Lacut, G. Le Gal, F. Couturaud, G. Cornily, C. Leroyer, D. Mottier, E. Oger, Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case–control study Fundamental & Clinical Pharmacology. ,vol. 21, pp. 643- 650 ,(2007) , 10.1111/J.1472-8206.2007.00515.X
Mika Omote, Hidesaku Asakura, Sayuri Takamichi, Masami Shibayama, Tomotaka Yoshida, Yasuko Kadohira, Mio Maekawa, Masahide Yamazaki, Eriko Morishita, Shinji Nakao, Takashi Wada, Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers. Thrombosis Research. ,vol. 123, pp. 390- 395 ,(2008) , 10.1016/J.THROMRES.2008.05.008
Anna K Jönsson, Erzsebet Horváth-Puhó, Staffan Hägg, Lars Pedersen, Henrik Toft Sørensen, Antipsychotics and risk of venous thromboembolism: A population-based case-control study. Clinical Epidemiology. ,vol. 1, pp. 19- 26 ,(2009) , 10.2147/CLEP.S4969